APA (7th ed.) Citation

Ha Young Jang, In-Wha Kim, & Jung Mi Oh. (2023). Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea. MDPI AG.

Chicago Style (17th ed.) Citation

Ha Young Jang, In-Wha Kim, and Jung Mi Oh. Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease Versus Normal Kidney Function: A Nationwide Cohort Study in Korea. MDPI AG, 2023.

MLA (9th ed.) Citation

Ha Young Jang, et al. Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease Versus Normal Kidney Function: A Nationwide Cohort Study in Korea. MDPI AG, 2023.